81 FR 22 pgs. 5763-5764 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Biosimilar User Fee Cover Sheet; Form FDA 3792
Type: NOTICEVolume: 81Number: 22Pages: 5763 - 5764
Pages: 5763, 5764Docket number: [Docket No. FDA-2012-N-0194]
FR document: [FR Doc. 2016-01883 Filed 2-2-16; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2012-N-0194]
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Biosimilar User Fee Cover Sheet; Form FDA 3792
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Biosimilar User Fee Cover Sheet; Form FDA 3792" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455 Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002, PRAStaff@fda.hhs.gov .
SUPPLEMENTARY INFORMATION:
[top] On June 23, 2015, the Agency submitted a proposed collection of information entitled "Biosimilar User Fee Cover Sheet; Form FDA 3792" to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0718. The approval expires on December 31, 2018. A copy of the supporting statement for this
Dated: January 28, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-01883 Filed 2-2-16; 8:45 am]
BILLING CODE 4164-01-P